 |
|
|
| |
BJT-778, anti-HBsAg monoclonal antibody, achieved 100% virologic response in subjects with chronic hepatitis D (CHD): phase 2 study results
|
| |
| |
AASLD 2024 Nov 15-19 San Diego
Kosh Agarwal, Marta Dobryanska , Alina Jucov, Patrick Kennedy, Edward J. Gane, Man-Fung Yuen, Grace Lai-Hung Wong, Simone Strasser, Jacinta Holmes, Stuart Roberts, Hassan Javanbakht, Nancy Shulman, Jenny C. Stanton
|
| |
|
|
|
|
|
